Investigator Initiated Trials (IITs) are an integral and increasingly important part of the clinical research landscape.
It can be challenging to provide the level of service and support needed, particularly for newer specialty medicines. To capture the full value of Investigator Initiated Trials while strengthening relationships with the investigator community, companies must have a flexible solution in place to address the time and resource demands of these variable study populations. Such solutions should include clear policies for all aspects of IIT programs, as Investigators and patients cannot afford delays and obstacles.
Clinigen’s Clinical Trial Services team has worked hand-in-hand with pharmaceutical companies to develop a state-of-the-art supply and distribution solution fit for current and future IIT demands. Our unique suite of dedicated IIT services deliver benefits to both bio-pharma and Investigators.